Specify a stock or a cryptocurrency in the search bar to get a summary
Caplin Point Laboratories Limited
CAPLIPOINTCaplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India. Address: Ashvich Tower, Chennai, India, 600096
Analytics
WallStreet Target Price
202 351.38 INRP/E ratio
30.1716Dividend Yield
0.26 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CAPLIPOINT
Dividend Analytics CAPLIPOINT
Dividend growth over 5 years
125 %Continuous growth
9 yearsPayout Ratio 5 years average
9 %Dividend History CAPLIPOINT
Stock Valuation CAPLIPOINT
Financials CAPLIPOINT
Results | 2019 | Dynamics |